OncoBeta
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lichtenbergstr. 8, Garching bei Munchen,...Phone Number
+49 8954842240Website
www.oncobeta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About OncoBeta
OncoBeta GmbH is a pioneering medical device and radiochemical company specializing in innovative therapies for non-melanoma skin cancers, particularly through their Rhenium-SCT treatment. This groundbreaking therapy utilizes the beta emitter radioisotope Rhenium-188, offering a painless and non-invasive solution for patients with basal cell carcinoma and squamous cell carcinoma. The company is committed to enhancing patient quality of life and has received regulatory approval from the Australian Therapeutic Goods Administration. OncoBeta also produces high-energy beta emitting Rhenium-188 generators for commercial use.Explore more
OncoBeta Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoBeta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if OncoBeta has recently received funding, and reach out quickly before it becomes old news!
Check out if OncoBeta is spiking on competitors!
OncoBeta, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if OncoBeta had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at OncoBeta
Earning: See what the market has to say on OncoBeta recently announced quarterly report
Funding: Get notified immidiatlly once OncoBeta has new funding data
Product Launch: Get notified when OncoBeta launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at OncoBeta
Find more new buyers
Company Profile Activity
Activity Insights
OncoBeta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OncoBeta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OncoBeta.
OncoBeta Tech Stack
A closer look at the technologies used by OncoBeta
OncoBeta News & Media
OncoBeta announces the expansion of Rhenium-SCT for non-melanoma skin cancer patients in Italy
BOZEN, Italy, Aug. 2, 2024 /PRNewswire/ -- OncoBeta®, a leading medical device company specialising in innovative epidermal radioisotope therapies, has announced the expansion of Rhenium-SCT® (Skin Cancer Therapy) treatment services in Italy with the Bolzano Hospital the latest to come on...OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
MADRID, June 20, 2024 /PRNewswire/ -- OncoBeta®, a leading medical device company specialising in innovative epidermal radioisotope therapies, today announced Hospital Universitario 12 de Octubre, in Madrid, has treated its first patient with Rhenium-SCT® (skin cancer therapy) – and is...Latest study demonstrates high efficacy in curing invasive non-melanoma skin cancer
Published: Tietze JK, et al. Clin Nucl Med. 2023;48(10):869–876. MUNICH, Oct. 25, 2023 /PRNewswire/ -- Results from a recently completed study show topical rhenium-188 skin cancer therapy to be a highly effective option for treating non-melanoma skin cancer (NMSC) of up to 3 mm...Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
MUNICH, July 11, 2023 /PRNewswire/ -- OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the phase IV international multi-centre study designed to further evaluate the Complete Response Rate of patients with non-melanoma skin...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoBeta
Sign Up For FreeTo access detailed company insights
OncoBeta GmbH is a pioneering medical device and radiochemical company specializing in innovative therapies for non-melanoma skin cancers, particularly through their Rhenium-SCT treatment. This groundbreaking therapy utilizes the beta emitter radioisotope Rhenium-188, offering a painless and non-invasive solution for patients with basal cell carcin... Read More
